miR-155 dysregulation and therapeutic intervention in multiple sclerosis

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

8 Citations (Scopus)

Abstract

microRNAs play a fundamental role in the immune system. One particular microRNA, miR-155 plays a critical role in hematopoietic cell development and tightly regulates innate and adaptive immune responses in response to infection. However, its dysregulation, more specifically its overexpression, is closely associated with various inflammatory disorders. The purpose of this review is to consolidate how miR-155 underpins a variety of processes that contribute to the pathology of multiple sclerosis (MS). In particular, the impact of miR-155 is discussed with respect to human pathology and animal models. How miR-155 contributes to the activation of pathogenic immune cells, the permeability of the blood-brain barrier, and neurodegeneration in relation to MS is described. Many environmental risk factors associated with MS susceptibility can cause upregulation of miR-155, while many of the current disease-modifying treatments may work by inhibiting miR-155. From this review, it is clear that miR-155 is a realistic and feasible diagnostic, prognostic, and therapeutic target for the treatment of MS.

Original languageEnglish
Title of host publicationRegulation of Inflammatory Signaling in Health and Disease
EditorsDakang Xu
Place of PublicationSingapore
PublisherSpringer
Chapter5
Pages111-131
Number of pages21
ISBN (Electronic)9789811059872
ISBN (Print)9789811059865
DOIs
Publication statusPublished - 2017

Publication series

NameAdvances in Experimental Medicine and Biology
PublisherSpringer
Volume1024
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Keywords

  • Astrocytes
  • Biomarker
  • Blood-brain barrier
  • Disease-modifying treatments
  • EAE
  • Environmental risk factors
  • Experimental autoimmune encephalomyelitis
  • Immunopathology
  • Macrophages
  • Microglia
  • MicroRNA
  • miR-155
  • Multiple sclerosis

Cite this

McCoy, C. E. (2017). miR-155 dysregulation and therapeutic intervention in multiple sclerosis. In D. Xu (Ed.), Regulation of Inflammatory Signaling in Health and Disease (pp. 111-131). (Advances in Experimental Medicine and Biology; Vol. 1024). Singapore: Springer. https://doi.org/10.1007/978-981-10-5987-2_5
McCoy, Claire E. / miR-155 dysregulation and therapeutic intervention in multiple sclerosis. Regulation of Inflammatory Signaling in Health and Disease. editor / Dakang Xu. Singapore : Springer, 2017. pp. 111-131 (Advances in Experimental Medicine and Biology).
@inbook{7b27d7a896cd49c28fe29fa9b0f1fb44,
title = "miR-155 dysregulation and therapeutic intervention in multiple sclerosis",
abstract = "microRNAs play a fundamental role in the immune system. One particular microRNA, miR-155 plays a critical role in hematopoietic cell development and tightly regulates innate and adaptive immune responses in response to infection. However, its dysregulation, more specifically its overexpression, is closely associated with various inflammatory disorders. The purpose of this review is to consolidate how miR-155 underpins a variety of processes that contribute to the pathology of multiple sclerosis (MS). In particular, the impact of miR-155 is discussed with respect to human pathology and animal models. How miR-155 contributes to the activation of pathogenic immune cells, the permeability of the blood-brain barrier, and neurodegeneration in relation to MS is described. Many environmental risk factors associated with MS susceptibility can cause upregulation of miR-155, while many of the current disease-modifying treatments may work by inhibiting miR-155. From this review, it is clear that miR-155 is a realistic and feasible diagnostic, prognostic, and therapeutic target for the treatment of MS.",
keywords = "Astrocytes, Biomarker, Blood-brain barrier, Disease-modifying treatments, EAE, Environmental risk factors, Experimental autoimmune encephalomyelitis, Immunopathology, Macrophages, Microglia, MicroRNA, miR-155, Multiple sclerosis",
author = "McCoy, {Claire E.}",
year = "2017",
doi = "10.1007/978-981-10-5987-2_5",
language = "English",
isbn = "9789811059865",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer",
pages = "111--131",
editor = "Xu, {Dakang }",
booktitle = "Regulation of Inflammatory Signaling in Health and Disease",

}

McCoy, CE 2017, miR-155 dysregulation and therapeutic intervention in multiple sclerosis. in D Xu (ed.), Regulation of Inflammatory Signaling in Health and Disease. Advances in Experimental Medicine and Biology, vol. 1024, Springer, Singapore, pp. 111-131. https://doi.org/10.1007/978-981-10-5987-2_5

miR-155 dysregulation and therapeutic intervention in multiple sclerosis. / McCoy, Claire E.

Regulation of Inflammatory Signaling in Health and Disease. ed. / Dakang Xu. Singapore : Springer, 2017. p. 111-131 (Advances in Experimental Medicine and Biology; Vol. 1024).

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

TY - CHAP

T1 - miR-155 dysregulation and therapeutic intervention in multiple sclerosis

AU - McCoy, Claire E.

PY - 2017

Y1 - 2017

N2 - microRNAs play a fundamental role in the immune system. One particular microRNA, miR-155 plays a critical role in hematopoietic cell development and tightly regulates innate and adaptive immune responses in response to infection. However, its dysregulation, more specifically its overexpression, is closely associated with various inflammatory disorders. The purpose of this review is to consolidate how miR-155 underpins a variety of processes that contribute to the pathology of multiple sclerosis (MS). In particular, the impact of miR-155 is discussed with respect to human pathology and animal models. How miR-155 contributes to the activation of pathogenic immune cells, the permeability of the blood-brain barrier, and neurodegeneration in relation to MS is described. Many environmental risk factors associated with MS susceptibility can cause upregulation of miR-155, while many of the current disease-modifying treatments may work by inhibiting miR-155. From this review, it is clear that miR-155 is a realistic and feasible diagnostic, prognostic, and therapeutic target for the treatment of MS.

AB - microRNAs play a fundamental role in the immune system. One particular microRNA, miR-155 plays a critical role in hematopoietic cell development and tightly regulates innate and adaptive immune responses in response to infection. However, its dysregulation, more specifically its overexpression, is closely associated with various inflammatory disorders. The purpose of this review is to consolidate how miR-155 underpins a variety of processes that contribute to the pathology of multiple sclerosis (MS). In particular, the impact of miR-155 is discussed with respect to human pathology and animal models. How miR-155 contributes to the activation of pathogenic immune cells, the permeability of the blood-brain barrier, and neurodegeneration in relation to MS is described. Many environmental risk factors associated with MS susceptibility can cause upregulation of miR-155, while many of the current disease-modifying treatments may work by inhibiting miR-155. From this review, it is clear that miR-155 is a realistic and feasible diagnostic, prognostic, and therapeutic target for the treatment of MS.

KW - Astrocytes

KW - Biomarker

KW - Blood-brain barrier

KW - Disease-modifying treatments

KW - EAE

KW - Environmental risk factors

KW - Experimental autoimmune encephalomyelitis

KW - Immunopathology

KW - Macrophages

KW - Microglia

KW - MicroRNA

KW - miR-155

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=85029715616&partnerID=8YFLogxK

U2 - 10.1007/978-981-10-5987-2_5

DO - 10.1007/978-981-10-5987-2_5

M3 - Chapter (Book)

SN - 9789811059865

T3 - Advances in Experimental Medicine and Biology

SP - 111

EP - 131

BT - Regulation of Inflammatory Signaling in Health and Disease

A2 - Xu, Dakang

PB - Springer

CY - Singapore

ER -

McCoy CE. miR-155 dysregulation and therapeutic intervention in multiple sclerosis. In Xu D, editor, Regulation of Inflammatory Signaling in Health and Disease. Singapore: Springer. 2017. p. 111-131. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-981-10-5987-2_5